39Indexed trials
mesh condition
Drug Resistant Epilepsy
Intelligence
Drug Resistant Epilepsy intelligence: 39 indexed trials, 15 recruiting studies, 33 sponsors across 32 countries.
15Recruiting
33Sponsors
32Countries
Leading sponsors
Hospices Civils de Lyon31 recruiting
Beijing Tiantan Hospital20 recruiting
UMC Utrecht21 recruiting
Xuanwu Hospital, Beijing22 recruiting
Assistance Publique Hopitaux De Marseille21 recruiting
Brigham and Women's Hospital11 recruiting
Biohaven Therapeutics Ltd.10 recruiting
Beijing Pins Medical Co., Ltd10 recruiting
Genovate-NaviFUS (Australia) Pty Ltd.11 recruiting
Duke University11 recruiting
Great Ormond Street Hospital for Children NHS Foundation Trust10 recruiting
Dartmouth-Hitchcock Medical Center11 recruiting
Geographic activity
United States13trials
France8trials
China5trials
Canada4trials
United Kingdom4trials
Netherlands3trials
Italy3trials
Poland2trials
Denmark2trials
India2trials
Australia2trials
Belgium2trials
Leading interventions
NaviFUS System2trials
Perampanel2trials
BHV-70001trials
Cannabidiol1trials
Cannabidiol (CBD) oral solution1trials
Cathodal Transcranial Direct Current Stimulation (tDCS).1trials
Combined Micro-Macro SEEG Electrodes1trials
Cedrus RB series response pad; Adtech Behnke-Fried micro-electrodes; Neuralynx or Blackrock electrophysiology system; Blackrock Cerestim or Natus Nicolet stimulator1trials
ECG1trials
ECoG sensing and stimulation1trials
EEG1trials
Blood and urine collection1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.